These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 9833594)

  • 21. Pharmacokinetics of ibuprofen enantiomers in plasma and suction blister fluid in healthy volunteers.
    Walker JS; Knihinicki RD; Seideman P; Day RO
    J Pharm Sci; 1993 Aug; 82(8):787-90. PubMed ID: 8377114
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Plasma and skin suction-blister-fluid pharmacokinetics and time course of the effects of oral mizolastine.
    Chosidow O; Dubruc C; Danjou P; Fuseau E; Espagne E; Bianchetti G; Thenot JP; Herson S; Rosenzweig P; Revuz J
    Eur J Clin Pharmacol; 1996; 50(4):327-33. PubMed ID: 8803528
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Teicoplanin, its pharmacokinetics, blister and peritoneal fluid penetration.
    Wise R; Donovan IA; McNulty CA; Waldron R; Andrews JM
    J Hosp Infect; 1986 Mar; 7 Suppl A():47-55. PubMed ID: 2871097
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparison of ceftazidime and cefamandole pharmacokinetics and blister fluid concentrations.
    Armstrong GC; Wise R; Brown RM; Hancox J
    Antimicrob Agents Chemother; 1981 Sep; 20(3):356-8. PubMed ID: 7030200
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Plasma and skin blister fluid concentrations of metronidazole and its hydroxy metabolite after oral administration.
    Klimowicz A; Nowak A; Bielecka-Grzela S
    Pol J Pharmacol; 1996; 48(1):47-52. PubMed ID: 9112627
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pharmacokinetics of ceftazidime in serum and suction blister fluid during continuous and intermittent infusions in healthy volunteers.
    Mouton JW; Horrevorts AM; Mulder PG; Prens EP; Michel MF
    Antimicrob Agents Chemother; 1990 Dec; 34(12):2307-11. PubMed ID: 2088186
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Interface-area-to-volume ratio of interstitial fluid in humans determined by pharmacokinetic analysis of netilmicin in small and large skin blisters.
    Blaser J; Rieder HL; Lüthy R
    Antimicrob Agents Chemother; 1991 May; 35(5):837-9. PubMed ID: 1854165
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Application of microdialysis to clinical pharmacokinetics in humans.
    Müller M; Schmid R; Georgopoulos A; Buxbaum A; Wasicek C; Eichler HG
    Clin Pharmacol Ther; 1995 Apr; 57(4):371-80. PubMed ID: 7712664
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Investigating paracetamol pharmacokinetics using venous and capillary blood and saliva sampling.
    Rittau AM; McLachlan AJ
    J Pharm Pharmacol; 2012 May; 64(5):705-11. PubMed ID: 22471366
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Correlations between theophylline concentrations in plasma, erythrocytes and cantharides-induced blister fluid and peak expiratory flow in asthma patients.
    Philip-Joet F; Bruguerolle B; Reynaud M; Arnaud A
    Eur J Clin Pharmacol; 1992; 43(5):563-5. PubMed ID: 1483497
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pharmacokinetics of brodimoprim in serum and skin blister fluid.
    Kalager T; Digranes A; Salveson A; Bergan T
    Chemotherapy; 1985; 31(6):405-9. PubMed ID: 4075857
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The comparative pharmacokinetics and tissue penetration of single-dose ciprofloxacin 400 mg i.v. and 750 mg po.
    Catchpole C; Andrews JM; Woodcock J; Wise R
    J Antimicrob Chemother; 1994 Jan; 33(1):103-10. PubMed ID: 8157550
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pharmacokinetic profile of meropenem, administered at 500 milligrams every 8 hours, in plasma and cantharidin-induced skin blister fluid.
    Maglio D; Teng R; Thyrum PT; Nightingale CH; Nicolau DP
    Antimicrob Agents Chemother; 2003 May; 47(5):1771-3. PubMed ID: 12709358
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Disposition and effects of flurbiprofen enantiomers in human serum and blister fluid.
    Oelkers R; Neupert W; Williams KM; Brune K; Geisslinger G
    Br J Clin Pharmacol; 1997 Feb; 43(2):145-53. PubMed ID: 9131946
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pharmacokinetics of oritavancin in plasma and skin blister fluid following administration of a 200-milligram dose for 3 days or a single 800-milligram dose.
    Fetterly GJ; Ong CM; Bhavnani SM; Loutit JS; Porter SB; Morello LG; Ambrose PG; Nicolau DP
    Antimicrob Agents Chemother; 2005 Jan; 49(1):148-52. PubMed ID: 15616289
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The pharmacokinetics and inflammatory fluid penetration of orally administered azithromycin.
    Cooper MA; Nye K; Andrews JM; Wise R
    J Antimicrob Chemother; 1990 Oct; 26(4):533-8. PubMed ID: 2174853
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antibiotic concentration in suction skin blister fluid and saliva after repeated dosage of erythromycin acistrate and erythromycin base.
    Tuominen RK; Männistö PT; Solkinen A; Vuorela A; Pohto P; Haataja H
    J Antimicrob Chemother; 1988 Jun; 21 Suppl D():57-65. PubMed ID: 3391876
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Diffusion of lipid fractions through the barrier of cantharidin blisters in hyperlipidemias under conditions of clofibrate and rutinosid interaction].
    Szamer B
    Ann Acad Med Stetin; 1993; 39():87-101. PubMed ID: 8154625
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Penetration of tinidazole into skin blister fluid following its oral administration.
    Klimowicz A; Nowak A; Bielecka-Grzela S
    Eur J Clin Pharmacol; 1992; 43(5):523-6. PubMed ID: 1483489
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Human plasma and skin blister fluid levels of griseofulvin after its repeated administration.
    Schäfer-Korting M; Korting HC; Mutschler E
    Eur J Clin Pharmacol; 1985; 29(3):351-4. PubMed ID: 4076331
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.